Portal de investigación
Banff 2022 pancreas transplantation multidisciplinary report: Refinement of guidelines for T cell-mediated rejection, antibody-mediated rejection and islet pathology. Assessment of duodenal cuff biopsies and noninvasive diagnostic methods
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Drachenberg, CB
- Buettner-Herold, M
- Aguiar, PV
- Horsfield, C
- Mikhailov, AV
- Papadimitriou, JC
- Seshan, S
- Perosa, M
- Boggi, U
- Uva, P
- Rickels, M
- Grzyb, K
- Arend, L
- Cuatrecasas, M
- Toniolo, MF
- Farris, AB
- Renaudin, K
- Zhang, LZ
- Roufousse, C
- Gruessner, A
- Gruessner, R
- Kandaswamy, R
- White, S
- Burke, G
- Cantarovich, D
- Parsons, RF
- Cooper, M
- Kudva, YC
- Kukla, A
- Haririan, A
- Parajuli, S
- Meier, R
- Dunn, T
- Ugarte, R
- Rao, JS
- Vistoli, F
- Stratta, R
- Odorico, J
Grupos
Abstract
The Banff pancreas working schema for diagnosis and grading of rejection is widely used for treatment guidance and risk stratification in centers that perform pancreas allograft biopsies. Since the last update, various studies have provided additional insight regarding the application of the schema and enhanced our understanding of additional clinicopathologic entities. This update aims to clarify terminology and lesion description for T cell - mediated and antibody -mediated allograft rejections, in both active and chronic forms. In addition, morphologic and immunohistochemical tools are described to help distinguish rejection from nonrejection pathologies. For the first time, a clinicopathologic approach to islet pathology in the early and late posttransplant periods is discussed. This update also includes a discussion and recommendations on the utilization of endoscopic duodenal donor cuff biopsies as surrogates for pancreas biopsies in various clinical settings. Finally, an analysis and recommendations on the use of donor -derived cell -free DNA for monitoring pancreas graft recipients are provided. This multidisciplinary effort assesses the current role of pancreas allograft biopsies and offers practical guidelines that can be helpful to pancreas transplant practitioners as well as experienced pathologists and pathologists in training.
Datos de la publicación
- ISSN/ISSNe:
- 1600-6135, 1600-6143
- Tipo:
- Article
- Páginas:
- 362-379
- PubMed:
- 37871799
- Factor de Impacto:
- 3,311 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
AMERICAN JOURNAL OF TRANSPLANTATION ELSEVIER SCIENCE INC
Citas Recibidas en Web of Science: 22
Documentos
- No hay documentos
Filiaciones
Keywords
- whole pancreas transplantation; simultaneous pancreas kidney; transplant; solitary pancreas transplant; pancreas after kidney transplant; acute Tcell-mediated rejection; antibody-mediated rejection; mixed rejection; donor-specific antibody; percutaneous pancreas biopsy
Campos de Estudio
Cita
Drachenberg CB,Buettner M,Aguiar PV,Horsfield C,Mikhailov AV,Papadimitriou JC,Seshan S,Perosa M,Boggi U,Uva P,Rickels M,Grzyb K,Arend L,Cuatrecasas M,Toniolo MF,Farris AB,Renaudin K,Zhang LZ,Roufousse C,Gruessner A,Gruessner R,Kandaswamy R,White S,Burke G,Cantarovich D,Parsons RF,Cooper M,Kudva YC,Kukla A,Haririan A,Parajuli S,MERINO J,ARGENTE M,Meier R,Dunn T,Ugarte R,Rao JS,Vistoli F,Stratta R,Odorico J. Banff 2022 pancreas transplantation multidisciplinary report: Refinement of guidelines for T cell-mediated rejection, antibody-mediated rejection and islet pathology. Assessment of duodenal cuff biopsies and noninvasive diagnostic methods. Am. J. Transplant. 2024. 24. (3):p. 362-379. IF:8,200. (1).